Instil Bio Inc expected to post a loss of $2.59 a share - Earnings Preview

Instil Bio

06/05/2025 14:54

Instil Bio Inc TIL.OQ TIL.O is expected to show no change in quarterly revenue when it reports  results on May 8 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Instil Bio Inc is for a loss of $2.59 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Instil Bio Inc is $110.00​, above​ its last closing price of $14.05. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-3.26
-3.22
-1.82
Beat
43.5
Sep. 30 2024
-2.33
-2.11
-3.54
Missed
-68
Jun. 30 2024
-2.99
-2.98
-2.29
Beat
23.2​
Mar. 31 2024
-2.22
-2.23
-3.74
Missed
-67.7
​​Dec. 31 2023
-2.29
-2.84
-1.99
Beat
30.1
Sep. 30 2023
-1.98
-2.00
-10.40
Missed
-420​
Jun. 30 2023
-3.47
-3.27
-2.80
Beat
14.3
Mar. 31 2023
-3.09
-3.10
-8.80
Missed
-183.9

This summary was machine generated May 6 at 13:54 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)